Medical network - March 8 February 23, people club department released the 2017 edition of medicare drug directory. According to a new directory, different interpretation of different industries. One interpretation is that "predict who will be a new health care by entry in a directory and market outbreak, annual sales of 1 billion yuan of variety", the idea was that in 2009 health care directory changes to the rocket shot up, some products to become number of annual sales of 1 billion yuan of "god".
This prediction, the author holds a different view. Because 2009 is completely different from the current medical market environment, the health reform began in the second half of 2015 has been a complete reversal of the previous policy and market pattern, extended the traditional inertial thinking is inappropriate, the conclusion must one false step will make a great difference.
Market environment has changed
Whether this new medical insurance directory of influence on the medical market or to assess the performance of pharmaceutical companies, not just the directory itself. New directory is an important link in health care, medical market trend is a result of the combined action of every link of the whole health care, pharmaceutical enterprise product marketing is a microcosm of the entire pharmaceutical market movements.
There is no doubt the importance of product into the medical insurance directory. Products, especially for slow disease because patients need long-term medication, whether into the effect of health care use and sales of product be reckoned, but in the context of today's, again it can produce 1 billion yuan "magic pill" almost impossible.
And it's not hard to find, and not every entered medical insurance directory (such as medical insurance directory 2009) products can be as a result the explosive growth of sales. Each "magic pill" almost all have a common characteristic -- injectable dosage forms, especially antibiotics and TCM injections. These "medicine" god can quickly shot up to the annual sales of 1 billion yuan, is improper use sales approach and transition.
Some varieties, each department can use, can't separate application treatment universal auxiliary "magic pill". Most of these "medicine" universal god USES the reserve agency model sales, rely on high commissions and kickbacks, without the need for academic promotion, can quickly achieve 1 billion yuan of annual sales.
At present, the "two votes" is the national policy, firmly implement has no doubt, and ticket verification, tax inspection and so on has made the traditional reserve agency model can no longer take hold. Has to reverse drug kickbacks, doctors pay reform and practice more, also made with gold sales risk is more and more big, finally can only die, in addition to pay for health care drugs policy and use of supervision, without the manufacturing "medicine" god "artifact," believe "god" is very difficult to reproduce.
Traditional Chinese medicine (TCM) injections evaluation again
2017 medicare drug directory fully respect the opinions of medical experts, can see the different treatment of medical experts in the field of medicine. For example: traditional Chinese medicine injection, the controversial drug adverse reaction in the CFDA statistics, the data has been high, neither as an independent drug treatment, and occupy large medical expenses, has been the industry known as "a category of universal god of medicine".
The new medical insurance directory of traditional Chinese medicine (TCM) injection for a larger proportion in the field of tumor treatment, and there is no limit to the level 2 above hospitals use, limited in middle-late or chemoradiation makes little sense to use it. Early use of traditional Chinese medicine injection is not much, because tumor and tumor patient most of the radiation and chemotherapy, so this limitation is only textual.
Formula contains ginseng injection of traditional Chinese medicines in the new directory listed as auxiliary medication directory, the payment standard will be restricted. And other treatments in the field of traditional Chinese medicine injection mostly confined to level 2 above hospitals use, or is limited to specific indications. Therefore, traditional Chinese medicine (TCM) injection is a must for tumor patients or tumor domain experts by the medical market infect more questionable, but it is unavoidable, every field medical experts is important one annulus in the past medical benefit pattern.
February 27, it is worth noting that the effectiveness and safety of traditional Chinese medicine injection and evaluation by the national agency on the important agenda, which is after the medicine medicine consistency evaluation, the important measures to strengthen management of drug quality. Predictably, the manufacturing process simple and rough, poor quality control, safety of traditional Chinese medicine injection will be eliminated in the process of evaluation again, will the brutal growth inhibition effect of traditional Chinese medicine (TCM) injection.
Greatly meet the needs of the treatment
On February 20, just two days before the official launch in the new health care catalogue, ministry of finance, people club department, national health development planning commission issued "on strengthening the basic medical insurance fund budget management give play to the role of medical insurance fund control of the opinions, 'in the beginning, points out that the unreasonable growth of medical expenses partly offset by the effect of government spending, increased social and individual responsibility. Thus, control the unreasonable growth of medical expense is the top priority of the file.
Documents made it clear that will set up a sound balance "retention, reasonable overruns share" incentive constraint mechanism, incentive medical institutions to improve service efficiency and quality. Macro-reforms, capitation payment is carried out, according to the payment methods, such as a bed, pay medical institutions pay standard, actual cost is lower than contract balance part by retention of medical institutions; Of the actual cost more than pay the standard, exceed a share shall be borne by the medical establishment, for the quality of the reasonable cost overruns can be on the basis of negotiations, Shared by medical institutions and medical insurance fund.
This would mean that doctors use, consumables have to pinch pennies. China will enter a strong health care medical regulatory era, and will be more and more strict!
We believe that, with the strict limit for resistance, TCM injections safety and effectiveness evaluation again, limit outpatient transfusion, medical insurance fund control, and a series of reform important measures in parallel, the policies to connect with each other, quickly produce 1 billion yuan level "magic pill" soil has ceased to exist. Medical insurance directory scope is extended, a greater extent to ensure people's needs for medical treatment, to produce "magic pill" impossible.
(the writer is the pharmaceutical industry, senior marketing experts, senior consultant) |
